Brazil's National Health Surveillance Agency (Anvisa) has approved the drug Awiqli, produced by the pharmaceutical company ...
A 46-year-old Mount Pearl resident, who has lived with diabetes since 2003, will be the first to receive a prescription for a ...
Awiqli has been cleared for both types of diabetes in all its current markets except China, where it can be used for type 2 only. “We believe in the potential of once-weekly basal insulin icodec ...
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorisation ...
Once-weekly insulin, and a new antibiotic Other highlights of the meeting included a positive opinion for Novo Nordisk’s Awiqli (insulin icodec) for adults with type 1 and 2 diabetes ...